Cyclooxygenase-2 inhibition: vascular inflammation and cardiovascular risk.

Current Atherosclerosis Reports
Francesco Cipollone, Maria Luigia Fazia

Abstract

The inducible isoform of cyclooxygenase-2 (COX-2) plays a role in pathophysiologic processes like inflammation and pain but is also constitutively expressed in tissues such as the kidney or vascular endothelium, where it exerts important physiologic functions. Although much evidence exists that implicates COX-2 in atherosclerosis, its role in this setting remains substantially uncertain. This observation is also confirmed by the results of clinical trials of selective COX-2 inhibitors. Treatment with these drugs, developed with the assumption that they would be as effective as nonselective COX inhibitors but without their gastrointestinal side effects, has been reported to be associated with an increased cardiovascular risk. In this article, we review the pattern of expression of COX-2 in the cellular players of atherothrombosis, its role as a determinant of plaque vulnerability, and the vascular effects on prostanoid inhibition by COX-2 inhibitors.

References

Apr 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·W L XieD L Simmons
Jan 1, 1984·Arteriosclerosis : an Official Journal of the American Heart Association, Inc·P H RollandA Serradimigni
Oct 28, 1994·Biochemical and Biophysical Research Communications·J A MaierF Pagani
May 5, 1994·The New England Journal of Medicine·C Patrono
Dec 1, 1996·Arteriosclerosis, Thrombosis, and Vascular Biology·J KreuzerW Kübler
Jan 6, 1999·Proceedings of the National Academy of Sciences of the United States of America·B F McAdamG A FitzGerald
Jan 14, 1999·The New England Journal of Medicine·R Ross
Nov 23, 2000·The New England Journal of Medicine·C BombardierUNKNOWN VIGOR Study Group
Mar 15, 2001·Proceedings of the National Academy of Sciences of the United States of America·D PraticòG A FitzGerald
Jun 20, 2001·The Journal of Clinical Investigation·W L Smith, R Langenbach
Aug 11, 2001·The New England Journal of Medicine·G A FitzGerald, C Patrono
May 29, 2002·Proceedings of the National Academy of Sciences of the United States of America·Bianca RoccaCarlo Patrono
Sep 17, 2002·Arteriosclerosis, Thrombosis, and Vascular Biology·Hiroyasu InoueToshiyuki Sasaguri
Oct 16, 2002·Arteriosclerosis, Thrombosis, and Vascular Biology·Francesco Cipollone, Carlo Patrono
Oct 16, 2002·Arteriosclerosis, Thrombosis, and Vascular Biology·Anastasia PapafiliGeoffrey J Laurent
Jan 16, 2003·Arthritis and Rheumatism·Colin Baigent, Carlo Patrono
Mar 11, 2003·Scandinavian Cardiovascular Journal : SCJ·Mette OlesenErling Falk
Jun 28, 2003·The Journal of Thoracic and Cardiovascular Surgery·Elisabeth OttUNKNOWN Ischemia Research and Education Foundation (IREF) Investigators
Nov 1, 2003·Arteriosclerosis, Thrombosis, and Vascular Biology·Francesco CipolloneCarlo Patrono
May 13, 2004·JAMA : the Journal of the American Medical Association·Francesco CipolloneUNKNOWN Identification of New Elements of Plaque Stability (INES) Study Group
May 25, 2004·Arteriosclerosis, Thrombosis, and Vascular Biology·Francesco CipolloneAndrea Mezzetti
Sep 17, 2004·The Journal of Clinical Investigation·Takuya KobayashiShuh Narumiya
Oct 8, 2004·The New England Journal of Medicine·Garret A Fitzgerald
Feb 17, 2005·The New England Journal of Medicine·Robert S BresalierUNKNOWN Adenomatous Polyp Prevention on Vioxx (APPROVe) Trial Investigators
Feb 17, 2005·The New England Journal of Medicine·Scott D SolomonUNKNOWN Adenoma Prevention with Celecoxib (APC) Study Investigators
Feb 17, 2005·The New England Journal of Medicine·Nancy A NussmeierKenneth M Verburg
Jul 16, 2005·Arteriosclerosis, Thrombosis, and Vascular Biology·Francesco CipolloneAndrea Mezzetti
Aug 17, 2005·Journal of Thrombosis and Haemostasis : JTH·F CipolloneA Mezzetti

❮ Previous
Next ❯

Citations

Jan 8, 2011·Heart and Vessels·Cristine SkogastiernaLena Ekström
Jul 29, 2008·The Journal of Nutritional Biochemistry·Yuanyuan ZhengBernhard Hennig
Apr 27, 2010·Veterinary Pathology·R S SellersN K Khan
Nov 4, 2009·The Korean Journal of Physiology & Pharmacology : Official Journal of the Korean Physiological Society and the Korean Society of Pharmacology·Soon Ae LeeWon Young Paik
Mar 22, 2012·Medicinal Research Reviews·Valérie CapraG Enrico Rovati
Nov 30, 2019·Journal of Biomolecular Structure & Dynamics·Arun Bahadur GurungAtanu Bhattacharjee
Jun 7, 2019·The Journal of Toxicological Sciences·Zaher A Radi, K Nasir Khan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.